Last updated at 20 Mar 2025 05:02 PM
Director
DIN: 05209323
Prity Sinha is currently associated with 4 companies as Director. They serve as a Director at XENONE HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05209323.Prity Sinha has previously been associated with 1 company in roles such as Additional Director.Prity Sinha is currently involved in 1 different role. Their most recent position is with ADEXA PHARMA PRIVATE LIMITED as a Director. The first company Prity Sinha was appointed to as a director was XENONE HEALTHCARE PRIVATE LIMITED. Prity Sinha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Prity Sinha is currently associated with 4 companies as Director. They serve as a Director at XENONE HEALTHCARE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05209323.Prity Sinha has previously been associated with 1 company in roles such as Additional Director.Prity Sinha is currently involved in 1 different role. Their most recent position is with ADEXA PHARMA PRIVATE LIMITED as a Director. The first company Prity Sinha was appointed to as a director was XENONE HEALTHCARE PRIVATE LIMITED. Prity Sinha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Female
India
Gain instant access to verified contact details.
Current Companies (4)
Current LLPs (0)
Past Companies (1)
2y 9m 1y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| XENONE HEALTHCARE PRIVATE LIMITED | Director | 21-Mar-2012 |
| ATLANTAS WORLDWIDE PRIVATE LIMITED | Director | 05-Aug-2013 |
| FORTUNE PHARMACEUTICALS INDIA PRIVATE LIMITED | Director | 30-Sep-2024 |
| ADEXA PHARMA PRIVATE LIMITED | Director | 07-Nov-2024 |